Drug Screen and Treatment Method
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 11, 2008
app pub date -
Nov 17, 2007
filing date -
Nov 17, 2006
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to methods identify or characterize compounds that can be used to treat specified clinical disorders such as hyperglycemia and type 2 diabetes. Compounds that can be used in these methods include 4.alpha.-fluoro-17.alpha.-ethynylandrost-5-ene-3.beta.,7.beta.,17.beta.-t-riol, 4.alpha.-fluoro-17.alpha.-ethynylandrost-5-ene-3.beta.,7.alpha.,17.b-eta.-triol, 4.alpha.-fluoro-17.alpha.-ethynylandrost-5-ene-3.alpha.,7.beta.,17.beta.--triol and 4.alpha.-fluoro-17.alpha.-ethynylandrost-5-ene-3.beta.,17.beta.--triol-7-one.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully